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Abstract
Two patients with no travel history and sharing the same room
were colonized by the same strain of New Delhi metallo-b-lac-
tamase 1 (NDM-1)-producing Escherichia coli within a geographical
area not endemic for this highly multidrug-resistant bacterium. It
was documented an absence of an epidemiological and bacterio-
logical link with a third patient returning from India after surgery
and found to be infected by an NDM-1-producing Citrobacter
strain during the same period. Despite extensive investigation, the
source of contamination of the two former patients was not eluci-
dated. This case report illustrates the need of investigating rapidly
the emergence of highly multidrug-resistant Enterobacteriaceae,
to stop their dissemination in a nosocomial setting.
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Enterobacteriaccae producing New Delhi metallo-b-lactam-
ase 1 (NDM-1) were shown recently to be an emerging
problem in public health [1,2]. Many cases have been
reported worldwide, including in European countries with no
close links with Asia [3].
An 86-year-old man (patient 1) was hospitalized for a hip
fracture in June 2010, and again for anaemia requiring blood
transfusions in July 2010 at the university hospital of Saint-Eti-
enne, France. Because of catheter-associated urinary tract
infection, four urinary samples were cultured (Fig. 1); the last
two specimens showed successively Enterococcus faecalis and
Escherichia coli, both of which exhibited a sensitive pattern with
current antimicrobial agents. These two infections were trea-
ted, respectively, with amoxycillin and ﬂuoroquinolone. The
patient was then discharged to a rehabilitation facility 25 km
from the ﬁrst setting. In October 2010, before being trans-
ferred to a long-term-care facility, he was found to be colonized
in urine and stools by a strain of E. coli resistant to many antimi-
crobial drugs, including aminoglycosides, ﬂuoroquinolones,
trimethoprim–sulphamethoxazole, penicillins, cephalosporins,
and carbapenems. The MICs of imipenem, ertapenem, mero-
penem and doripenem interpreted according to CLSI guidelines
[4] were 4, 4, 1 and 1.5 mg/L, respectively. The strain was sensi-
tive to colistin and tigecyclin (MIC of 0.5 mg/L for both drugs).
With PCR techniques speciﬁc for b-lactam resistance genes,
this strain tested positive for three b-lactamase genes (TEM-1,
OXA-10, and CMY-16) and for the NDM-1 gene [5].
In the course of the epidemiological investigation related
to the discovery of this case of colonization involving an
NDM-1-positive bacterium, an 85-year-old patient sharing
the same room (patient 2) was found to be colonized at the
intestinal level by a similar E. coli strain, in terms of both
antibiotic resistance and genotypic pattern by rep-PCR-based
ﬁngerprinting with Diversilab (bioMe´rieux, Marcy l’e´toile,
France). This patient had been previously hospitalized in Sep-
tember and October 2010 in the neurosurgery unit of the
university hospital of Saint-Etienne (Fig. 1).
With a follow-up of 7 months, patient 1 was found to be
chronically contaminated at both the intestinal and urinary
tract levels; by contrast, patient 2 tested negative 3 months
later. Both patients denied any travel outside France during
the last 5 years.
Within the same period (August 2010), an 18-year-old
female (patient 3) repatriated from Pondicherry, India was
found to be infected with a multiresistant strain of Citrobacter
freundii harbouring the NDM-1 gene [6]. The infection was
limited to the urinary tract, and ceased after the removal of
the urinary catheter. No intestinal colonization was
observed, despite an exhaustive screening including 15 suc-
cessive samplings during the next 3 months (Fig. 1).
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In order to address the potential relationship between
these episodes, a large epidemiological investigation was per-
formed, notably because patients 2 and 3 had been hospital-
ized in the same neurosurgery ward within a 2-month
period, despite a gap of 5 weeks between the two stays
(Fig. 1). As shown in Table 1, patients sharing the same
healthcare team were divided into two groups according to
the time of implementation of hygienic contact precaution
measures. From a total of 269 presumed contact patients,
195 (72.5%) could be sampled by rectal swabbing, as recom-
mended by recent French guidelines [7]. With the exception
of the cross-transmission described above in the rehabilita-
tion facility (cases 1 and 2 in Table 1), no secondary case
was detected. Fig. 1 reports the temporal course of the
three cases with NDM-1-positive strains of Enterobacteriaceae
and of four other patients (A–D) who could have constituted
an epidemiological link between patients 2 and 3 in the neu-
rosurgery ward, because they had been present in this ward
either for a long period of time (patients A and B) or for
two successive stays matching those of patients 1 and 3
(patients C and D), despite no documented contact with the
index cases. These four patients tested negative for NDM-1-
positive isolates in rectal swabs (Fig. 1). In addition, a cross-
sectional investigation consisting of rectal swabbing of all
patients present in the neurosurgery ward was performed
on the 9 November 2010; it identiﬁed no further case of
colonization. The spouses of patients 1 and 2 who received
chronic care in other facilities (haemodialysis and long-term-
care units, respectively) also screened negative for NDM-1-
producing isolates by rectal swabbing.
From a bacteriological point of view, additional experi-
ments, with the Kieser method [8] and a PCR-based replicon
typing method [9], were conducted to type the NDM-1 plas-
mids in E. coli and C. freundii strains. The E. coli strains were
found to harbour a 150-kb plasmid, belonging to Inc type A/C
and carrying the associated resistant determinants OXA-10
and CMY-16. By contrast, the C. freundii strain harboured a
65-kb plasmid (pSTE-1) that was found to be untypeable in
the Inc classiﬁcation [6].
This case report illustrates the ability of multidrug-resis-
tant NDM-1-producing E. coli strains to spread in patients
sharing the same environment. A few cases of cross-trans-
mission of multidrug-resistant NDM-1-producing Enterobacte-
riaceae strains have been published previously [3]. To the
FIG. 1. Temporal diagram of cases harbouring NDM-1-producing bacteria (patients 1–3) and contacts (patients A–D) according to their hospital
location(s). Arrows and tips represent the times of stool and urine samplings, respectively; plain symbols correspond to samples found to be
positive for an NDM-1-producing bacterium.
TABLE 1. Epidemiological investigation performed in contact patients of the three cases found to be infected or colonized by
an NDM-1-producing bacterium; all of the patients tested negative at least once by rectal swabbing for the presence of bacte-
ria harbouring the NDM-1 gene
Case no. Ward and facility
Patients sharing the same healthcare team
Before implantation of contact precaution
measures





Total Tested Sample mean
per patient
1 Rehabilitation facility 47 43 2.3 – – –
2 Neurosurgery unit 75 32 1.5 – – –
Rehabilitation facility 42 40 2.1 – – –
3 Neurosurgery unit 55 42 1.7 30 27 1.8
Rehabilitation unita 14 5 1.0 6 6 3.0
aThe rehabilitation unit of the university hospital is a different place from the rehabilitation facility.
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best of our knowledge, our case report is the second one to
document nosocomial transmission of an NDM-1 gene
involving an E. coli strain. The ﬁrst one, published very
recently, concerned a cluster of septicaemic newborns with
possible transfer of NDM-1 genes from imipenem-resistant
Gram-negative bacilli to imipenem-susceptible E. coli [10].
These observations deserve special attention, because, in
contrast to other Enterobacteriaceae, E. coli is a constant inha-
bitant of the human digestive tract; they suggest that such
highly multidrug-resistant strains should be rapidly investi-
gated to stop their dissemination in a nosocomial setting.
A further peculiarity of this episode is that it occurred
concomitantly with another case of infection caused by an
NDM-1-producing bacterium in the more usual context of
repatriation from India [1,11]. Despite the simultaneity of
these cases in a same area at the same time, extensive bacte-
riological (different plasmids) and epidemiological investiga-
tions (Table 1) formally excluded a common origin. The
source of contamination of patients 1 and 2 remains
unknown. External sources, such as endoscopes or contact
with medical students who had worked in Asian hospitals
during holidays, were excluded (data not shown). A possible
explanation lies in the digestive colonization of a healthcare
worker who had travelled abroad. In fact, the colonization
by NDM-1-producing strains of healthy people returning
from Asia with [12] or without [13] stay in healthcare set-
tings has been previously reported. As multiple units had
harboured the two patients, a systematic screening at the
digestive level of healthcare workers was difﬁcult to perform,
especially because this measure is not recommended by cur-
rent French guidelines [7]. Previous reports have docu-
mented the autochthonous acquisition of NDM-1-producing
Enterobacteriaceae, including Morganella morganii and Providen-
cia rettgeri [14] and Klebsiella pneumoniae [15], in patients
with no history of travel in areas known to be endemic for
NDM-1-producing strains. As in our cases, the source of
contamination of these three patients remained unknown.
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